Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

Cheung, Angel; Gong, Mengqi; Bellanti, Roberto; Ali-Hasan-Al-Saegh, Sadeq; Li, Guangping; Roig, Eulalia; Nunez, Julio; Stamos, Thomas; YILMAZ, MEHMET; Hakki, Kaya; Wu, William; Wong, Sunny; Wong, Wing; Bazoukis, George; Lampropoulos, Konstantinos; Tse, Lah; Zhao, Jichao; Lip, Gregory; Baranchuk, Adrian; Wong, Martin; Liu, Tong; Tse, Gary

doi:10.1136/heartasia-2017-010970

Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis

Atıf İçin Kopyala

Cheung A., Gong M., Bellanti R., Ali-Hasan-Al-Saegh S., Li G., Roig E., ...Daha Fazla

HEART ASIA, cilt.10, sa.1, 2018 (ESCI)

Yayın Türü: Makale / Derleme
Cilt numarası: 10 Sayı: 1
Basım Tarihi: 2018
Doi Numarası: 10.1136/heartasia-2017-010970
Dergi Adı: HEART ASIA
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background Cancer antigen-125 (Ca-125) is traditionally recognised as a tumour marker and its role in cardiovascular diseases has been studied only in recent years. Whether Ca-125 is elevated in patients with atrial fibrillation (AF) and its levels predict the risk of AF remains controversial. Therefore, we conducted a systematic review and meta-analysis of the association between Ca-125 levels and AF.